Global Stents Market to exceed USD 14 Bn by 2025

December 11, 2019


According to the new research report available at MarketStudyReport.com under the title ‘Stents Market Size By Product (Vascular Stents [Coronary Stents {Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents}, Peripheral Stents {Iliac Stents, Femoral-popliteal Stents, Renal Stents, Carotid Stents}, Neurovascular Stents], Non-vascular Stents), By Material (Metal, Polymer), By Type (Self-expendable Stents, Balloon-expendable Stents), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025’, the worldwide stents market is anticipated to surpass US $14 billion by the year 2025.
 

Increasing occurrence of cardiovascular diseases owing to the adoption of unhealth and sedentary lifestyle is expected to drive the demand of stents market. Rising geriatric population which is susceptible to heart blockages and require PCI (peripheral coronary intervention) procedure will trigger the market growth further. In addition, consumer preference for minimally invasive procedure and inflowing investment towards R&D for improved stents will be the major drivers for expansion of stents market over the forecast timeframe.
 

In terms of product, vascular stents segment was worth US $9 billion in 2018, owing to increasing prevalence of cardiovascular diseases among the global population. Vascular segment includes coronary, neurovascular, and peripheral stents. While the other product is non-vascular stents.
 

Based on material, stents market from polymer segment is presumed to grow with a CAGR of 6.5% over the forecast period, pertaining to high compatibility of the product along with less post-surgery complications, cites the report.
 

Speaking of type, self-expandable stents market is projected to accrue more than US $5 billion by the year 2025. The segmental growth is attributed to longer patency rates, improved durability, and use of product for treating patients with femoropopliteal disease.
 

On the basis of end-use spectrum, stents market from hospital segments accounted for 75% revenue share in 2018 and is presumed to register modest growth over the analysis period, on account of patient preference for hospital settings. These facilities follow strict guidelines ensuring patient safety and have advanced surgical equipment resulting in better surgical outcomes. 
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2361907/
 

Considering the regional landscape, Japan stents market is anticipated to expand with a CAGR of 6.2% during the period of 2019-2025, due to growing instances of heart related disorders and availability of numerous cardiovascular surgeries in the region.
 

The prominent companies operating in stents market include Meril Life Sciences, Abbott Laboratories, Elixir Medical Corporation, B. Braun Melsungen AG, Biosensors International Group, Microport Scientific Corporation, Terumo, Medtronic, Biotronic, and Boston Scientific.


Frequently Asked Questions (FAQ) :

Increasing occurrence of cardiovascular diseases owing to the adoption of unhealth and sedentary lifestyle is expected to drive the demand of stents market. Rising geriatric population which is susceptible to heart blockages and require PCI (peripheral coronary intervention) procedure will trigger the market growth further. In addition, consumer preference for minimally invasive procedure and inflowing investment towards R&D for improved stents will be the major drivers for expansion of stents market over the forecast timeframe.
Japan stents market is anticipated to expand with a CAGR of 6.2% during the period of 2019-2025, due to growing instances of heart related disorders and availability of numerous cardiovascular surgeries in the region.
Based on material, stents market from polymer segment is presumed to grow with a CAGR of 6.5% over the forecast period, pertaining to high compatibility of the product along with less post-surgery complications, cites the report.
The prominent companies operating in stents market include Meril Life Sciences, Abbott Laboratories, Elixir Medical Corporation, B. Braun Melsungen AG, Biosensors International Group, Microport Scientific Corporation, Terumo, Medtronic, Biotronic, and Boston Scientific.